For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Group A- Bevacizumab Alone | Bevacizumab 15 mg/kg every 3 wks for 1 year | None | None | 1 | 40 | 40 | 40 | View |
| Group B-Bevacizumab+Cyclophosphamide+Methotrexate | Bevacizumab 15 mg/kg every 3 weeks for 1 year +Cyclophosphamide 50 mg orally daily for 6 months +methotrexate 2.5mg orally on day 1-2 each week for 6 months. | None | None | 3 | 41 | 41 | 41 | View |
| Group C-Bevacizumab + Capcitabine(18 Wks) | capecitabine 2000 mg/m2/day 14 days on/7 days off for 18 weeks, and bevacizumab 15 mg/kg every 3 weeks for 1 year | None | None | 1 | 41 | 41 | 41 | View |
| Group D-bevacizumab + Capecitibine (24wks) | capecitabine 2000 mg orally twice per day for 7 days on/7 days off for 24 weeks, and bevacizumab 15 mg/kg every 3 weeks for 1 year. | None | None | 1 | 40 | 40 | 40 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Death | SYSTEMATIC_ASSESSMENT | General disorders | NCTCAE v.3 | View |
| Dyspnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCTCAE v.3 | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCTCAE v.3 | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCTCAE v.3 | View |
| Wound Dehiscence | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCTCAE v.3 | View |
| Sinusitis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCTCAE v.3 | View |
| Lower GI bleed | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCTCAE v.3 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| ALT, SGPT | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | NCTCAE v.3 | View |
| AST, SGOT | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | NCTCAE v.3 | View |
| Abdomen, pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCTCAE v.3 | View |
| Alkaline phosphatase | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | NCTCAE v.3 | View |
| Allergic rhinitis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCTCAE v.3 | View |
| Agitation | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | NCTCAE v.3 | View |
| Allergic Reaction | SYSTEMATIC_ASSESSMENT | Immune system disorders | NCTCAE v.3 | View |
| Alopecia | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCTCAE v.3 | View |
| Anorexia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCTCAE v.3 | View |
| Anxiety | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | NCTCAE v.3 | View |
| Arthritis | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCTCAE v.3 | View |
| back,pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCTCAE v.3 | View |
| bicarbonate | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCTCAE v.3 | View |
| bilirubin | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCTCAE v.3 | View |
| bone, pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCTCAE v.3 | View |
| Dyspepsia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Edema limb | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCTCAE v.3 | View |
| Erythema multiforme | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCTCAE v.3 | View |
| Extrapyramidal movement | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCTCAE v.3 | View |
| Extremity-limb, pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCTCAE v.3 | View |
| fatigue | SYSTEMATIC_ASSESSMENT | General disorders | NCTCAE v.3 | View |
| febrile neutropenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCTCAE v.3 | View |
| fever w/o neutropenia | SYSTEMATIC_ASSESSMENT | General disorders | NCTCAE v.3 | View |
| flatulence | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCTCAE v.3 | View |
| Gastrointestinal-other | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCTCAE v.3 | View |
| Hand-foot reaction | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCTCAE v.3 | View |
| Head/headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCTCAE v.3 | View |
| hematologic-other | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCTCAE v.3 | View |
| hemoglobin | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCTCAE v.3 | View |
| hemorrhage-other | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCTCAE v.3 | View |
| hemorrhoids | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCTCAE v.3 | View |
| Hot flashes | SYSTEMATIC_ASSESSMENT | General disorders | NCTCAE v.3 | View |
| hypercalcemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCTCAE v.3 | View |
| Hyperglycemia | SYSTEMATIC_ASSESSMENT | Endocrine disorders | NCTCAE v.3 | View |
| Hyperkalemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCTCAE v.3 | View |
| Hypernatremia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCTCAE v.3 | View |
| Hyperpigmentation | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCTCAE v.3 | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCTCAE v.3 | View |
| Hypoalbuminemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCTCAE v.3 | View |
| Hypocalcemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCTCAE v.3 | View |
| Hypoglycemia | SYSTEMATIC_ASSESSMENT | Endocrine disorders | NCTCAE v.3 | View |
| Hypokalemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCTCAE v.3 | View |
| Hyponatremia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCTCAE v.3 | View |
| Infection Gr0-2 neut, bronchus | SYSTEMATIC_ASSESSMENT | Infections and infestations | NCTCAE v.3 | View |
| Infection Gr0-2 neut, sinus | SYSTEMATIC_ASSESSMENT | Infections and infestations | NCTCAE v.3 | View |
| Infection Gr0-2 neut, skin | SYSTEMATIC_ASSESSMENT | Infections and infestations | NCTCAE v.3 | View |
| Infection Gr0-2 neut, upper airway | SYSTEMATIC_ASSESSMENT | Infections and infestations | NCTCAE v.3 | View |
| Infection Gr0-2 neut, urinary tract | SYSTEMATIC_ASSESSMENT | Infections and infestations | NCTCAE v.3 | View |
| Infection w/unk ANC upper airway NOS | SYSTEMATIC_ASSESSMENT | Infections and infestations | NCTCAE v.3 | View |
| Infection-other | SYSTEMATIC_ASSESSMENT | Infections and infestations | NCTCAE v.3 | View |
| Insomnia | SYSTEMATIC_ASSESSMENT | General disorders | NCTCAE v.3 | View |
| irregular menses | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | NCTCAE v.3 | View |
| joint, pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCTCAE v.3 | View |
| joint-function | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCTCAE v.3 | View |
| Leukocytes | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCTCAE v.3 | View |
| Memory impairment | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCTCAE v.3 | View |
| Metabolic/laboratory-other | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCTCAE v.3 | View |
| Muco/stomatitis(symptom) oral cavity | SYSTEMATIC_ASSESSMENT | Infections and infestations | NCTCAE v.3 | View |
| Muco/stomatitis by exam, oral cavity | SYSTEMATIC_ASSESSMENT | Infections and infestations | NCTCAE v.3 | View |
| Muscle, pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCTCAE v.3 | View |
| Musculoskeletal/soft tissue-other | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCTCAE v.3 | View |
| Nail changes | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCTCAE v.3 | View |
| Nasal cavity/paranasal sinus reaction | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCTCAE v.3 | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCTCAE v.3 | View |
| Neck,pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCTCAE v.3 | View |
| Neuropathy-sensory | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCTCAE v.3 | View |
| Neutrophils | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCTCAE v.3 | View |
| Nonneuropathic generalized weakness | SYSTEMATIC_ASSESSMENT | General disorders | NCTCAE v.3 | View |
| Nose, hemorrhage | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCTCAE v.3 | View |
| Oral cavity, hemorrhage | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCTCAE v.3 | View |
| Oral gums, pain | SYSTEMATIC_ASSESSMENT | General disorders | NCTCAE v.3 | View |
| Pain NOS | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCTCAE v.3 | View |
| Pain-other | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCTCAE v.3 | View |
| Palpitations | SYSTEMATIC_ASSESSMENT | Cardiac disorders | NCTCAE v.3 | View |
| Platelets | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCTCAE v.3 | View |
| Proteinuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | NCTCAE v.3 | View |
| Pruritus/itching | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCTCAE v.3 | View |
| Pulmonary/upper respiratory-other | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCTCAE v.3 | View |
| Radiation dermatitis | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCTCAE v.3 | View |
| Rash/desquamation | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCTCAE v.3 | View |
| Rash: acne/acneiform | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCTCAE v.3 | View |
| Rectum, hemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCTCAE v.3 | View |
| Rigors/chills | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCTCAE v.3 | View |
| Skin-other | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Sweating | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Taste disturbance | SYSTEMATIC_ASSESSMENT | General disorders | NCTCAE V3 | View |
| Tearing | SYSTEMATIC_ASSESSMENT | Eye disorders | NCTCAE V3 | View |
| Throat/Pharynx/larynx,pain | SYSTEMATIC_ASSESSMENT | General disorders | NCTCAE V3 | View |
| Vagina, hemorrhage | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | NCTCAE V3 | View |
| Vaginal discharge (non-infectious) | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | NCTCAE V3 | View |
| Vaginal dryness | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | NCTCAE V3 | View |
| Vision-blurred | SYSTEMATIC_ASSESSMENT | Eye disorders | NCTCAE V3 | View |
| Voice changes/dysarthria | SYSTEMATIC_ASSESSMENT | General disorders | NCTCAE V3 | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCTCAE V3 | View |
| Weight Gain | SYSTEMATIC_ASSESSMENT | General disorders | NCTCAE V3 | View |
| Wound-non-infectious | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCTCAE V3 | View |
| Cardiac-other | SYSTEMATIC_ASSESSMENT | Cardiac disorders | NCTCAE V3 | View |
| bruising | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCTCAE v.3 | View |
| buttock, pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCTCAE v.3 | View |
| Chelitis | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCTCAE v.3 | View |
| chest wall, pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCTCAE v.3 | View |
| Chest/thoracic pain NOS | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCTCAE v.3 | View |
| Constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCTCAE v.3 | View |
| Constitutional, other | SYSTEMATIC_ASSESSMENT | General disorders | NCTCAE v.3 | View |
| Cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCTCAE v.3 | View |
| creatinine | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | NCTCAE v.3 | View |
| Depression | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | NCTCAE v.3 | View |
| Diarrhea w/o prior colostomy | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCTCAE v.3 | View |
| Dizziness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCTCAE v.3 | View |
| Dry Eye Syndrome | SYSTEMATIC_ASSESSMENT | Eye disorders | NCTCAE v.3 | View |
| Dry Mouth | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCTCAE v.3 | View |
| Dry Skin | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCTCAE v.3 | View |
| Dyspnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCTCAE v.3 | View |
| breast,pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCTCAE v.3 | View |